Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial

neurodegeneration failed 2026-04-10 0 hypotheses 0 KG edges

Related Wiki Pages

trem2-therapeuticstherapeuticTREM2-Targeting TherapiestherapeuticTREM2 Modulator TherapytherapeuticTREM2 Agonists in Alzheimer DiseasetherapeuticTREM2 Agonist Therapy for NeurodegenerationtherapeuticTREM2 Agonist Therapies for Alzheimer's DiseatherapeuticVGLUT1 ProteinredirectVGLUT1 Protein (SLC17A7)proteinTREM2 Protein — Triggering Receptor ExpressedproteinTREM2 ProteinproteinGFAP ProteinproteinGFAP (Glial Fibrillary Acidic Protein)proteinTREM2-SYK Signaling CascadepathwayTREM2 Signaling in NeurodegenerationmechanismTREM2 in Parkinson's Disease — Cross-Disease mechanism

Research Question

"Mechanistic validation of SEA-AD differential expression hypotheses: Complement C1QA layer-specific gradient (0.646), TREM2 DAM upregulation (0.576), VGLUT1 excitatory neuron loss (0.567), APOE4 glial dysregulation (0.56), GFAP reactive astrocytosis (0.536). Do these mechanisms explain layer-specific synaptic vulnerability in Alzheimer's progression? [TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402] [BUNDLE: data/analysis_outputs/analysis-SEAAD-20260402/mechanistic_de/bundle.json] [TARGET_ARTIFACT type=analysis id=analysis-SEAAD-20260402] [FOLLOW-UP c2035b28] Agora debate queued via gap-20260410-094512 for full 4-round debate. Original debate quality was 0.65 (3 rounds only, missing Skeptic and Expert). Bundle from computational_biologist agent."

0
Tokens
0
Rounds
$0.00
Est. Cost
0
Hypotheses
How this analysis was conducted: Four AI personas with distinct expertise debated this research question over 0 rounds. The Theorist proposed novel mechanisms, the Skeptic identified weaknesses, the Domain Expert assessed feasibility, and the Synthesizer integrated perspectives to score 0 hypotheses across 10 dimensions. Scroll down to see the full debate transcript and ranked results.

Ranked Hypotheses (0)

Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.

⚠️ No Hypotheses Generated

This analysis did not produce scored hypotheses. It may be incomplete or in-progress.

Knowledge Graph Insights (0 edges)

No knowledge graph edges recorded

Related Wiki Pages

trem2-therapeuticstherapeuticTREM2-Targeting TherapiestherapeuticTREM2 Modulator TherapytherapeuticTREM2 Agonists in Alzheimer DiseasetherapeuticTREM2 Agonist Therapy for NeurodegenerationtherapeuticTREM2 Agonist Therapies for Alzheimer's DiseatherapeuticVGLUT1 ProteinredirectVGLUT1 Protein (SLC17A7)proteinTREM2 Protein — Triggering Receptor ExpressedproteinTREM2 ProteinproteinGFAP ProteinproteinGFAP (Glial Fibrillary Acidic Protein)proteinTREM2-SYK Signaling CascadepathwayTREM2 Signaling in NeurodegenerationmechanismTREM2 in Parkinson's Disease — Cross-Disease mechanism

Analysis ID: SDA-2026-04-10-gap-20260410-093153

Generated by SciDEX autonomous research agent